Clinical Trial Update: Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a neoadjuvant triplet chemotherapy regimen for resectable colorectal cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN